| Interleukin-12 and-23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria JH Bernink, L Krabbendam, K Germar, E de Jong, K Gronke, ... Immunity 43 (1), 146-160, 2015 | 654 | 2015 |
| c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies JH Bernink, Y Ohne, MBM Teunissen, J Wang, J Wu, L Krabbendam, ... Nature immunology 20 (8), 992-1003, 2019 | 161 | 2019 |
| KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2− ILCs biased toward ILC2 or ILC3 M Nagasawa, BA Heesters, CMA Kradolfer, L Krabbendam, ... Journal of Experimental Medicine 216 (8), 1762-1776, 2019 | 111 | 2019 |
| New insights into the function, development, and plasticity of type 2 innate lymphoid cells L Krabbendam, SM Bal, H Spits, K Golebski Immunological reviews 286 (1), 74-85, 2018 | 84 | 2018 |
| FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming IS Hansen, L Krabbendam, JH Bernink, F Loayza-Puch, W Hoepel, ... Nature communications 9 (1), 863, 2018 | 51 | 2018 |
| Innate lymphoid cells: from helper to killer L Krabbendam, JH Bernink, H Spits Current opinion in immunology 68, 28-33, 2021 | 45 | 2021 |
| Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease MD Hazenberg, NJE Haverkate, YF van Lier, H Spits, L Krabbendam, ... Blood advances 3 (22), 3650-3660, 2019 | 32 | 2019 |
| CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn’s disease L Krabbendam, BA Heesters, CMA Kradolfer, NJE Haverkate, MAJ Becker, ... Nature communications 12 (1), 5841, 2021 | 28 | 2021 |
| Identification of human cytotoxic ILC3s L Krabbendam, BA Heesters, CMA Kradolfer, H Spits, JH Bernink European journal of immunology 51 (4), 811-823, 2021 | 27 | 2021 |
| Isolation of human innate lymphoid cells L Krabbendam, M Nagasawa, H Spits, SM Bal Current protocols in immunology 122 (1), e55, 2018 | 24 | 2018 |
| Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF‐dependent mechanism Z Bánki, L Krabbendam, D Klaver, T Leng, S Kruis, H Mehta, B Müllauer, ... Immunology and cell biology 97 (6), 538-551, 2019 | 19 | 2019 |
| Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations EK van der Ploeg, L Krabbendam, H Vroman, M van Nimwegen, ... Nature Communications 14 (1), 5137, 2023 | 4 | 2023 |
| GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation YF van Lier, L Krabbendam, NJE Haverkate, SS Zeerleder, B Blom, ... Frontiers in immunology 13, 1020590, 2022 | 2 | 2022 |
| Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies JH Bernink, Y Ohne, MBM Teunissen, J Wang, J Wu, L Krabbendam, ... Nature immunology 21 (1), 101-101, 2020 | 2 | 2020 |
| Interleukin-12 and-23 Control Plasticity of CD127 JH Bernink, L Krabbendam, K Germar, E de Jong, K Gronke, ... Immunity. Elsevier Inc, 1-16, 2015 | 2 | 2015 |
| Human CD127 negative ILC2s show immunological memory L Matha, L Krabbendam, S Martinez-Hoyer, B Heesters, K Golebski, ... bioRxiv, 2023.10. 29.564625, 2023 | 1 | 2023 |
| Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history CM van Zelst, J CCM, L Krabbendam, GM de Boer, MJW de Bruijn, ... ERJ Open Research 10 (1), 2024 | | 2024 |
| WS14. 06 Single cell RNA sequencing of lung biopsies reveals altered immune-structural cell crosstalk in cystic fibrosis L Krabbendam, M Berg, M Van Nimwegen, T Van der Veer, M Banchero, ... Journal of Cystic Fibrosis 22, S29, 2023 | | 2023 |
| Differences in Innate Lymphoid Cell profiles between COPD, asthma, smoking controls and non-smoking healthy controls C van Zelst, JIT Veen, G De Boer, M De Bruijn, M Van Nimwegen, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
| Three clinical phenotypes of COPD with each a characteristic immunological profile C van Zelst, JIT Veen, M De Bruijn, M Van Nimwegen, E Van Der Ploeg, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
